16.12.2019 • News

ADNOC and Reliance to Study EDC Plant at Ruwais

ADNOC and Reliance to Study EDC Plant at Ruwais (c) Dirk Ercken/Shutterstock
ADNOC and Reliance to Study EDC Plant at Ruwais (c) Dirk Ercken/Shutterstock

Abu Dhabi National Oil Company (ADNOC) and India’s Reliance Industries (RIL) plan to jointly explore production of ethylene dichloride (EDC) in a new facility that would be built adjacent to the United Arab Emirates-based oil and petrochemicals producer’s refinery complex at Ruwais in Abu Dhabi.

The companies said the new cooperation would enhance their existing relationship while supporting future collaboration in petrochemicals and would have advantages for both sides.

Reliance would provide operational knowhow for the EDC plant, with ADNOC supplying ethylene. The Abu Dhabi oil giant would gain indirect access to the Indian PVC market and the Indian company would benefit from the “world-class infrastructure” at Ruwais, where ADNOC and Vienna-based olefins and polyolefins producer Borealis operate the Borouge joint venture.

This would be RIL’s third major link-up with a global energy company so far in this year. In August, it announced a joint venture for its fuel retail business with BP and sale of a 25% stake in its oil-to-chemicals business to Saudi Aramco.

Abdulaziz Alhajri, CEO of Borouge, said the agreement with Reliance is a product of a strong relationship spanning more than two decades and a testament to ADNOC’s continued ability to cultivate smart and mutually beneficial international partnerships.

Alhajri said ADNOC, will “work closely with RIL to identify opportunities to capitalize on the strengths of the Ruwais ecosystem, while delivering a compelling new commercial platform for satisfying the large Indian PVC market.”

Nikhil Meswani, executive director of Reliance, said the company’s “significant step toward backward integration will pave the way for enhancing PVC capacity in India to cater to the fast growing domestic market.”

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.